Official Sections CTRMS ISVCA IPITA IPTA ISODP IRTA IXA SPLIT TID

2017 - IXA

This page contains exclusive content for the member of the following sections: TTS, IXA

FDA-IXA Workshop - The Challenge of Infection and Risk-Benefit in Xenotransplantation

2.5 - Calibrating the Risk:Benefit Ratio for Clinical Xeno Trial Design

Presenter: David , Sachs, Boston, United States
Authors:

Calibrating the Risk:Benefit Ratio for Clinical Xeno Trial Design David Sachs, Director, TBRC Laboratories, CTS, Massachusetts General Hospital, Boston, MA, United States

Important Disclaimer

By viewing the material on this site you understand and accept that:

  1. The opinions and statements expressed on this site reflect the views of the author or authors and do not necessarily reflect those of The Transplantation Society and/or its Sections.
  2. The hosting of material on The Transplantation Society site does not signify endorsement of this material by The Transplantation Society and/or its Sections.
  3. The material is solely for educational purposes for qualified health care professionals.
  4. The Transplantation Society and/or its Sections are not liable for any decision made or action taken based on the information contained in the material on this site.
  5. The information cannot be used as a substitute for professional care.
  6. The information does not represent a standard of care.
  7. No physician-patient relationship is being established.